Bioasis Technologies Inc. — Investor Relations & Filings
Filings indexed
120
across all filing types
Latest filing
2023-06-20
Regulatory Filings
Country
CA
Canada
Listing
TSXV
BIOAF
Bioasis Technologies Inc. is a development-stage biopharmaceutical company focused on the research and development of proprietary technologies and products for Central Nervous System (CNS) diseases and brain-related disorders. Its core technology is the xB3 platform, a proprietary system designed to facilitate the transport and delivery of therapeutic agents across the challenging blood-brain barrier (BBB). The company's in-house programs aim to develop both symptomatic and disease-modifying treatments, as well as diagnostic technologies, addressing the limitations inherent in treating complex neurological conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2023-06-20 | English | |
| News release - English.pdf | 2023-03-23 | English | |
| Material change report - English.pdf | 2023-02-01 | English | |
| News release - English.pdf | 2023-01-23 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 13676673 | News release - English.pdf | 2023-06-20 | English | ||
| 13655121 | News release - English.pdf | 2023-03-23 | English | ||
| 13641805 | Material change report - English.pdf | 2023-02-01 | English | ||
| 26889150 | News release - English.pdf | 2023-01-23 | English | ||
| 13640993 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-01-19 | English | ||
| 13640992 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-01-19 | English | ||
| 13641004 | Interim MD&A - English.pdf | 2023-01-19 | English | ||
| 13640995 | Interim financial statements/report – English.pdf | 2023-01-19 | English | ||
| 13640996 | News release - English.pdf | 2023-01-19 | English | ||
| 13640997 | News release - English.pdf | 2023-01-19 | English | ||
| 13638871 | News release - English.pdf | 2023-01-11 | English | ||
| 13638942 | Other.pdf | 2023-01-11 | English | ||
| 13638941 | Other.pdf | 2023-01-11 | English | ||
| 13638940 | Other.pdf | 2023-01-11 | English | ||
| 13638939 | Other.pdf | 2023-01-11 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adaptogenics Health Corp.
Formulates and distributes functional mushroom and adaptoge…
|
ADPT | CA | Manufacturing |
|
Adastra Holdings
Manufacturer and supplier of ethnobotanical and processed c…
|
XTRX | CA | Manufacturing |
|
ADBIOTECH Co.,Ltd.
Develops IgY-based immune antibodies as alternatives to vac…
|
179530 | KR | Manufacturing |
|
ADC Therapeutics SA
Commercial-stage biotech developing antibody-drug conjugate…
|
ADCT | US | Manufacturing |
|
Addex Therapeutics Ltd.
Clinical-stage biopharma developing allosteric modulators f…
|
ADXN | CH | Manufacturing |
|
Adeshwar Meditex Limited
Manufacturer and exporter of medical disposables, surgical …
|
543309 | IN | Manufacturing |
|
ADIAL PHARMACEUTICALS, INC.
A clinical-stage biopharma developing genetically targeted …
|
ADIL | US | Manufacturing |
|
Adicet Bio, Inc.
Develops allogeneic gamma delta T cell therapies for cancer…
|
ACET | US | Manufacturing |
|
ADIMMUNE CORPORATION
Develops and manufactures human vaccines and biologics for …
|
4142 | TW | Manufacturing |
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
Bioasis Technologies Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/46038/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=46038 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=46038 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=46038 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 46038}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bioasis Technologies Inc. (id: 46038)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.